Human Leptin: An Adipocyte Hormone with Weight-Regulatory and Endocrine Functions

Robert V. Considine

doi:10.1055/s-2005-871738

Seminars in Vascular Medicine, Table of Contents

Semin Vasc Med 2005; 5(1): 15-24
DOI: 10.1055/s-2005-871738

Human Leptin: An Adipocyte Hormone with Weight-Regulatory and Endocrine Functions

Robert V. Considine¹

¹Indiana University School of Medicine, Indianapolis, Indiana

Abstract

ABSTRACT

Leptin is synthesized and secreted primarily by adipocytes, and is present in serum in direct proportion to the amount of adipose tissue. The primary role of leptin is to provide to the central nervous system a signal of energy intake and energy stores in the body so that the hypothalamus can efficiently maintain a stable body weight. The receptor for leptin in the hypothalamus signals by activation of an associated janus kinase which phosphorylates signal transducer and activator of transcription (STAT) proteins that regulate neuronal gene expression. Genetic mutations in leptin and its receptor can result in obesity in both rodents and humans, supporting a central role for leptin in the regulation of body weight. Leptin has also been implicated in a variety of physiological processes other than body weight homeostasis. Many of these functions are mediated through the central nervous system; however, the presence of leptin receptors in tissues throughout the body suggests that leptin can also have direct effects on cells and tissues. Serum leptin levels have been associated with cardiovascular risk factors after correction for adiposity. Leptin can promote platelet aggregation, which requires expression of functional leptin receptors on the platelet. Leptin-induced increases in sympathetic nerve activity have been suggested to contribute to hypertension, and leptin has been observed to increase oxidative stress in cultured endothelial cells. Many of these pathophysiologic effects of leptin on the vasculature are most likely of importance when leptin levels are elevated in obese subjects due to resistance to the weight-reducing effects of the hormone. An improved understanding of the effects of leptin on the vasculature will provide valuable insight into the relationship between obesity and cardiovascular disease.

KEYWORDS

Obesity - hyperleptinemia - hypertension - angiogenesis - thrombosis - oxidative stress

Full Text

References

REFERENCES

1 Kenchaiah S, Evans J C, Levy D et al.. Obesity and the risk of heart failure. N Engl J Med. 2002; 347 305-313
2 Sowers J R. Obesity as a cardiovascular risk factor. Am J Med. 2003; 115 37S-41S
3 Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance and cardiovascular disease. Recent Prog Horm Res. 2004; 59 207-223
4 Lyon C J, Law R E, Hseuh W A. Minireview: adiposity, inflammation and atherogenesis. Endocrinology. 2003; 144 2195-2200
5 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L. Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372 425-432
6 Cohen S L, Halaas J L, Friedman J M, Chait B T. Human leptin characterization. Nature. 1996; 382 589
7 Considine R V. Regulation of leptin production. Rev Endocr Metab Disord. 2001; 2 357-363
8 Tartaglia L A. The leptin receptor. J Biol Chem. 1997; 272 6093-6096
9 Vaisse C, Halaas J L, Horvath C M, Darnell Jr J E, Stoffel M, Friedman J M. Leptin activation of STAT3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet. 1996; 14 95-97
10 Niswender K D, Morton G J, Stearns W H, Rhodes C J, Myers Jr M G, Schwartz M W. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature. 2001; 413 794-795
11 Zhao A Z, Huan J N, Gupta S, Pal R, Sahu A. A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat Neurosci. 2002; 5 727-728
12 Lee G H, Proenca R, Montez J M et al.. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996; 379 632-635
13 Wang M -Y, Zhou Y T, Newgard C B, Unger R H. A novel leptin receptor isoform in rat. FEBS Lett. 1996; 392 87-90
14 Bjorbaek C, Uotani S, da Silva B, Flier J S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem. 1997; 272 32686-32695
15 Tartaglia L A, Dembski M, Weng X et al.. Identification and expression cloning of the a leptin receptor, OB-R. Cell. 1995; 83 1263-1271
16 Banks W A, Kastin A J, Huang W, Jaspan J B, Maness L M. Leptin enters the brain by a saturable system independent of insulin. Peptides. 1996; 17 305-311
17 Golden P L, Maccagnan T J, Pardridge W M. Human blood-brain barrier leptin receptor. J Clin Invest. 1997; 99 14-18
18 Sinha M K, Opentanova I, Ohannesian J P et al.. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest. 1996; 98 1277-1282
19 Houseknecht K L, Mantzoros C S, Kuliawat R, Hadro E, Flier J S, Kahn B B. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes. 1996; 45 1638-1643
20 Huang L, Wang Z, Li C. Modulation of circulating leptin levels by its soluble receptor. J Biol Chem. 2001; 276 6343-6349
21 Moon B C, Friedman J M. The molecular basis of the obese mutation in ob^2j mice. Genomics. 1997; 42 152-156
22 Chen H, Charlat O, Tartaglia L A et al.. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996; 84 491-495
23 Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim M H, Skoda R C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A. 1996; 93 6231-6235
24 Friedman J M. Leptin, leptin receptors, and the control of body weight. Nutr Rev. 1998; 56 S38-S48
25 Phillips M S, Liu Q, Hammond H A et al.. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet. 1996; 13 18-19
26 Chua Jr S C, White D W, Wu-Peng S et al.. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (lepr). Diabetes. 1996; 45 1141-1143
27 White D W, Wang D W, Chua Jr S C, Morgenstern J P, Leibel R L. Constitutive and impaired signaling of leptin receptors containing the Gln-Pro extracellular domain mutation. Proc Natl Acad Sci USA. 1997; 94 10657-10662
28 Takaya K, Ogawa Y, Hiraoka J et al.. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet. 1996; 14 130-131
29 Wu-Peng S, Chua Jr S C, Okada N, Lui S M, Nicolson M, Leibel R L. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma to CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes. 1997; 46 513-518
30 Caro J F, Considine R V. Leptin: From laboratory to clinic. in GA Bray, C Bouchard Handbook of Obesity, Clinical Applications, 2nd ed. New York; Marcel Dekker 2004: 275-295
31 Zigman J M, Elmquist J K. Minireview: From anorexia to obesity-the yin and yang of body weight control. Endocrinology. 2003; 144 3749-3756
32 Hickey M S, Israel R G, Gardiner S N et al.. Gender differences in serum leptin levels in humans. Biochem Mol Med. 1996; 59 1-6
33 Rosenbaum M, Leibel R L. Clinical Review 107. Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin. J Clin Endocrinol Metab. 1999; 84 1784-1789
34 Montague C T, Prins J B, Sanders L, Digby J, Orahilly S. Depot and sex specific differences in human leptin mRNA expression. Diabetes. 1997; 46 342-347
35 Lefebvre A M, Laville M, Vega N et al.. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes. 1998; 47 98-103
36 Van Harmelen V, Reynisdotir S, Eriksson P et al.. Leptin secretion from subcutaneous and visceral adipose tissue of women. Diabetes. 1998; 47 913-917
37 Fried S K, Kral J G. Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int J Obes. 1987; 11 129-140
38 Fried S K, Russell C D, Grauso N L, Brolin R E. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest. 1993; 92 2191-2198
39 Sih R, Morley J E, Kaiser F E, Perry 3rd H M, Patrick P, Ross C. Testosterone replacement in older hypogondal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997; 82 1661-1667
40 Jockenhovel F, Blum W F, Vogel E et al.. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab. 1997; 82 2510-2513
41 Mantzoros C S, Flier J S, Rogol A D. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab. 1997; 82 1066-1070
42 Elbers J M, Asscheman H, Seidell J C, Frolich M, Meinders A E, Gooren L J. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab. 1997; 82 3267-3270
43 Casabiell X, Pineiro V, Peino R et al.. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab. 1998; 83 2149-2155
44 Pineiro V, Casabiell X, Peino R et al.. Dihydrotestosterone, stanozol, androstenedione and dehydroepiandrosterone sulphate inhibit leptin secretion in female but not male samples of omental adipose tissue in vitro: lack of effect of testosterone. J Endocrinol. 1999; 160 425-432
45 Caro J F, Sinha M K, Kolaczynski J W, Zhang P L, Considine R V. Leptin: the tale of an obesity gene. Diabetes. 1996; 45 1455-1462
46 Sinha M, Ohannesian J P, Heiman M L, Kriauciunas A, Stephens T W, Magosin S, Marco C, Caro J F. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 1996; 97 1344-1347
47 Kolaczynski J W, Considine R V, Ohannesian J et al.. Responses of leptin to short-term fasting and refeeding in humans: A link with ketogenesis but not ketones themselves. Diabetes. 1996; 45 1511-1515
48 Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 1996; 81 3419-3423
49 Wisse B E, Campfield L A, Marliss E B, Morais J A, Tenenbaum R, Gougeon R. Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women. Am J Clin Nutr. 1999; 70 321-330
50 Schoeller D A, Cella L K, Sinha M K, Caro J F. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest. 1997; 100 1882-1887
51 Havel P J, Townsend R, Chaump L, Teff K. High fat meals reduce 24 h circulating leptin concentrations in women. Diabetes. 1999; 48 334-341
52 Teff K L, Elliott S S, Tschop M et al.. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab. 2004; 89 2963-2972
53 Saad M F, Khan A, Sharma A, Michael R, Road-Gabriel M G, Boyadjian R, Jinagouda S D, Steil G M, Kamdar V. Physiological insulinemia acutely modulates plasma leptin. Diabetes. 1998; 47 544-549
54 Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes. 1996; 45 1364-1366
55 Mueller W M, Gregoire F M, Stanhope K L et al.. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology. 1998; 139 551-558
56 Rossetti L. Perspective: hexosamines and nutrient sensing. Endocrinology. 2000; 141 1922-1925
57 McClain D A, Alexander T, Cooksey R C, Considine R V. Hexosamines stimulate leptin production in transgenic mice. Endocrinology. 2000; 141 1999-2002
58 Considine R V, Cooksey R C, Williams L B et al.. Hexosamines regulate leptin production in human subcutaneous adipocytes. J Clin Endocrinol Metab. 2000; 85 3551-3556
59 Donahoo W T, Jensen D R, Yost T J, Eckel R H. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab. 1997; 82 4139-4143
60 Pinkney J H, Coppack S W, Mohamed Ali V. Effect of isoproterenol on plasma leptin and lipolysis in humans. Clin Endocrinol (Oxf). 1998; 48 407-411
61 Stumvoll M, Fritsche A, Tschritter O et al.. Leptin levels in humans are acutely suppressed by isoproterenol despite Acipomox-induced inhibition of lipolysis, but not by free fatty acids. Metabolism. 2000; 49 335-339
62 Slieker L J, Sloop K W, Surface P L et al.. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem. 1996; 271 5301-5304
63 Kosaki A, Yamada K, Kuzuya H. Reduced expression of the leptin gene (ob) by catecholamine through a Gs protein-coupled pathway in 3T3-L1 adipocytes. Diabetes. 1996; 45 1744-1749
64 Ricci M R, Fried S K. Isoproterenol decreases leptin expression in adipose tissue of obese humans. Obes Res. 1999; 7 233-240
65 Flier J S. Clinical Review 94. What’s in a name? In search of leptin’s physiologic role. J Clin Endocrinol Metab. 1998; 83 1407-1413
66 Ahima R S, Prabakaran D, Mantzoros C et al.. Role of leptin in the neuroendocrine response to fasting. Nature. 1996; 382 250-252
67 Chan J L, Heist K, DePaoli A M, Veldhuis J D, Mantzoros C S. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest. 2003; 111 1409-1421
68 Van Heek M, Compton D S, France C F et al.. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest. 1997; 99 385-390
69 El-Haschimi K, Pierroz D D, Hileman S M, Bjorbaek C, Flier J S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest. 2000; 105 1827-1832
70 Bjorbaek C, Elmquist J K, Frantz J D, Shoelson S E, Flier J S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell. 1998; 1 619-625
71 Montague C T, Farooqi I S, Whitehead J P et al.. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997; 387 903-908
72 Rau H, Reaves B J, O'Rahilly S, Whitehead J P. Truncated human leptin (delta133) associated with extreme obesity undergoes proteasomal degradation after defective intracellular transport. Endocrinology. 1999; 140 1718-1723
73 Farooqi I S, O'Rahilly S. Monogenic human obesity syndromes. Recent Prog Horm Res. 2004; 59 409-424
74 Strobel A, Issad T, Camoin L, Ozata M, Strosberg A D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998; 18 213-215
75 Clement K, Vaisse C, Lahlou N et al.. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998; 392 398-401
76 Lahlou N, Clement K, Carel J C et al.. Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes. 2000; 49 1347-1352
77 Farooqi I S, Matarese G, Lord G M et al.. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002; 110 1093-1103
78 Heymsfield S B, Greenberg A S, Fujioka K et al.. Recombinant leptin for weight Loss in obese and lean adults. JAMA. 1999; 282 1568-1575
79 Pelleymounter M A, Cullen M J, Baker M B et al.. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995; 269 540-543
80 Schwartz M W, Baskin D G, Bukowski T R et al.. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 1996; 45 531-535
81 Sivitz W I, Walsh S A, Morgan D A, Thomas M J, Haynes W G. Effects of leptin on insulin sensitivity in normal rats. Endocrinology. 1997; 138 3395-3401
82 Kamohara S, Burcelin R, Halaas J L, Friedman J M, Charron M J. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997; 389 374-377
83 Shimomura I, Hammer R E, Ikemoto S, Brown M S, Goldstein J L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999; 401 73-76
84 Ebihara K, Ogawa Y, Masuzaki H et al.. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipatrophic diabetes. Diabetes. 2001; 50 1440-1448
85 Berti L, Kellerer M, Capp E, Haring H U. Leptin stimulates glucose transport and glycogen synthesis in C₂C₁₂ myotubes: evidence for a PI3-kinase mediated effect. Diabetologia. 1997; 40 606-609
86 Kim Y-B, Uotani S, Pierroz D D, Flier J S, Kahn B B. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology. 2000; 141 2328-2339
87 Fruhbeck G. Peripheral actions of leptin and its involvement in disease. Nutr Rev. 2002; 60 S47-S55
88 Orci L, Cook W S, Ravazzola M et al.. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci USA. 2004; 101 2058-2063
89 Henson MC, Castracane VD Leptin and Reproduction. Kluwer Academic New York; 2003
90 Lord G. Role of leptin in immunology. Nutr Rev. 2002; 60 S35-S38
91 Rahmouni K, Haynes W G. Leptin and the cardiovascular system. Recent Prog Horm Res. 2004; 59 225-244
92 Mark A L, Correia M L, Rahmouni K, Haynes W G. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens. 2002; 20 1245-1250
93 Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes. 1999; 48 426-429
94 Konstantinides S, Schafer K, Koschnick S, Loskutoff D J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest. 2001; 108 1533-1540
95 Soderberg S, Olsson T, Eliasson M, Johnson O, Ahren B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med. 1999; 245 533-543
96 Collins S, Kuhn C M, Petro A E, Swick A G, Chrunyk B A, Surwit R S. Role of leptin in fat regulation. Nature. 1996; 380 677
97 Haynes W G, Morgan D A, Walsh S A, Mark A L, Sivitz W I. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997; 100 270-278
98 Dunbar J C, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997; 46 2040-2043
99 Lembo G, Vecchione C, Fratta L et al.. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes. 2000; 49 293-297
100 Vecchione C, Maffei A, Colella S et al.. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002; 51 168-173
101 Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes. 1999; 48 903-908
102 Gardiner S M, Kemp P A, March J E, Bennett T. Regional haemodynamic effects of recombinant murine or human leptin in conscious rats. Br J Pharmacol. 2000; 130 805-810
103 Mitchell J L, Morgan D A, Correia M L, Mark A L, Sivitz W I, Haynes W G. Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?. Hypertension. 2001; 38 1081-1086
104 Quehenberger P, Exner M, Sunder-Plassmann R et al.. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 2002; 90 711-718
105 Singhal A, Farooqi I S, Cole T J et al.. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation. 2002; 106 1919-1924
106 Sierra-Honigmann M R, Nath A K, Murakami C et al.. Biological action of leptin as an angiogenic factor. Science. 1998; 281 1683-1686
107 Bouloumie A, Drexler H C, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998; 83 1059-1066
108 Schafer K, Halle M, Goeschen C et al.. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol. 2004; 24 112-117
109 Harrison D, Griendling K K, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003; 91 7A-11A
110 Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999; 13 1231-1238
111 Yamagishi S I, Edelstein D, Du X L, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem. 2001; 276 25096-25100

Robert V ConsidinePh.D.

Indiana University School of Medicine

541 N. Clinical Dr., Rm. CL455

Indianapolis, IN 46202